Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuriko Nagane
Observed names:
Nagane, Yuriko,
Y Nagane,
Y. Nagane
Institution:
General Hanamaki Hospital
Observed institutions:
Tokyo Medical University,
Chiba University,
Iwate Medical University,
Keio University,
Toho University Ohashi Medical Center,
General Hanamaki Hospital,
The University of Osaka
show all 7
ORCID:
0000-0003-2464-8947
Observed ORCID:
0000-0003-2464-8947
OpenAlex ID:
A5057180618
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2017
·
James F Howard
, Kimiaki Utsugisawa
, et al.
·
The Lancet Neurology
·
889
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
2023
·
Vera Bril
, Artur Drużdż
, et al.
·
The Lancet Neurology
·
321
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
2023
·
James F Howard
, Saskia Bresch
, et al.
·
The Lancet Neurology
·
305
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
2009
·
Shigeaki Suzuki
, Kimiaki Utsugisawa
, et al.
·
Archives of Neurology
·
188
Reduction with age in methylcytosine in the promoter region −224∼−101 of the amyloid precursor protein gene in autopsy human cortex
1999
·
Hideo Tohgi
, Kimiaki Utsugisawa
, et al.
·
Molecular Brain Research
·
180
International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r
2016
·
Ted M. Burns
, Reza Sadjadi
, et al.
·
Muscle & Nerve
·
169
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis
2020
·
A Uzawa
, S Kuwabara
, et al.
·
Clinical & Experimental Immunology
·
163
PDF
Efficacy of Low-Dose FK506 in the Treatment of Myasthenia gravis – A Randomized Pilot Study
2005
·
Yuriko Nagane
, Kimiaki Utsugisawa
, et al.
·
European Neurology
·
106
Three Types of Striational Antibodies in Myasthenia Gravis
2011
·
Shigeaki Suzuki
, Kimiaki Utsugisawa
, et al.
·
Autoimmune Diseases
·
105
PDF
Health‐related quality‐of‐life and treatment targets in myasthenia gravis
2014
·
Kimiaki Utsugisawa
, Shigeaki Suzuki
, et al.
·
Muscle & Nerve
·
104
The MG‐QOL15 Japanese version: Validation and associations with clinical factors
2012
·
Masayuki Masuda
, Kimiaki Utsugisawa
, et al.
·
Muscle & Nerve
·
101
Cardiac involvements in myasthenia gravis associated with anti‐ K v1.4 antibodies
2013
·
S. Suzuki
, A. Baba
, et al.
·
European Journal of Neurology
·
95
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
2020
·
Renato Mantegazza
, Gil I. Wolfe
, et al.
·
Neurology
·
87
PDF
Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis
2012
·
Tomoko Masuda
, Masakatsu Motomura
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
87
PDF
Early fast‐acting treatment strategy against generalized myasthenia gravis
2016
·
Kimiaki Utsugisawa
, Yuriko Nagane
, et al.
·
Muscle & Nerve
·
83
PDF
Clinical and immunological differences between early and late-onset myasthenia gravis in Japan
2010
·
Shigeaki Suzuki
, Kimiaki Utsugisawa
, et al.
·
Journal of Neuroimmunology
·
81
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
2017
·
Yuriko Nagane
, Hiroyuki Murai
, et al.
·
BMJ Open
·
78
The methylation status of cytosines in a τ gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex
1999
·
Hideo Tohgi
, Kimiaki Utsugisawa
, et al.
·
Neuroscience Letters
·
72
Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study
2011
·
Yasushi Suzuki
, Kimiaki Utsugisawa
, et al.
·
BMJ Open
·
69
PDF
Eculizumab improves fatigue in refractory generalized myasthenia gravis
2019
·
Henning Andersen
, Renato Mantegazza
, et al.
·
Quality of Life Research
·
61
PDF
Early Aggressive Treatment Strategy against Myasthenia Gravis
2010
·
Yuriko Nagane
, Shigeaki Suzuki
, et al.
·
European Neurology
·
60
Age-related changes in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human frontal cortex and hippocampus
1998
·
Hideo Tohgi
, Kimiaki Utsugisawa
, et al.
·
Neuroscience Letters
·
56
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
2023
·
Akiyuki Uzawa
, Shigeaki Suzuki
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
54
Rationale for the clinical guidelines for myasthenia gravis in Japan
2018
·
Hiroyuki Murai
, Kimiaki Utsugisawa
, et al.
·
Annals of the New York Academy of Sciences
·
53
Factors associated with response to calcineurin inhibitors in myasthenia gravis
2009
·
Yuriko Nagane
, Shigeaki Suzuki
, et al.
·
Muscle & Nerve
·
53
Show more works
View as search
Works count:
128
Citation count:
4,915
H-index:
35
I10-index:
71
Year
Topic
Type
